No­var­tis makes it of­fi­cial: Al­con is mov­ing its HQ from Texas to Gene­va ahead of a spin­off

Al­con is los­ing its Texas ac­cent.

No­var­tis $NVS CEO Vas Narasimhan put out the word this morn­ing that the Basel-based phar­ma gi­ant is mov­ing Al­con’s head­quar­ters to Gene­va — ahead of a planned spin­off and pub­lic list­ing next year.

Af­ter the move the big No­var­tis eye care di­vi­sion will have up to 700 peo­ple based in the tax-friend­ly Swiss can­ton, which al­ready hosts a large re­gion­al group. And Al­con will make its cur­rent head­quar­ters in Fort Worth, Texas a di­vi­sion of the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER